Effectiveness of the IP1 on cardio-metabolic risk factors of type2 diabetes (pre-post analysis)
Systolic and diastolic BP were significantly lower among IP1 consumers in the evaluation than in the baseline AβC = -3.5mmHg (95% CI: -5.78 to -1.24) and AβC = -5.9mmHg (95% CI: -7.34 to -4.44) respectively. Further, fasting blood glucose was higher in the evaluation phase than the baseline phase AβC = 0.49 mmol/L (95% CI: 0.31 to 0.67) (